Shares of Innate Pharma (IPHA) are on the rise for a second straight session on Tuesday following an article in the journal Nature that opened up the possibility that the company and partner AstraZeneca (AZN) could explore the use of cancer drug monalizumab against COVID-19. POTENTIAL USE OF… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3059127/-Innate-rises-again-on-potential-use-of-cancer-drug-against-COVID)